Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Greenwich LifeSciences, Inc. (GLSI) had Return on Tangible Equity of -317.51% for the most recently reported fiscal quarter, ending 2024-12-31.
Income Statement Financials | |
-- |
|
$-8.04M |
|
-- |
|
-- |
|
$8.08M |
|
$-8.08M |
|
$0.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.04M |
|
$-8.08M |
|
$-8.08M |
|
13.02M |
|
13.02M |
|
$-0.62 |
|
$-0.62 |
|
Balance Sheet Financials | |
$4.09M |
|
-- |
|
$0.00M |
|
$4.09M |
|
$1.56M |
|
-- |
|
-- |
|
$1.56M |
|
$2.53M |
|
$2.53M |
|
$2.53M |
|
13.15M |
|
Cash Flow Statement Financials | |
$-7.27M |
|
-- |
|
$4.37M |
|
$6.99M |
|
$4.09M |
|
$-2.90M |
|
$7.25M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-317.29% |
|
Return on Tangible Equity |
-317.51% |
-196.40% |
|
-317.29% |
|
$0.19 |
|
$-0.56 |
|
$-0.56 |